Geriatric Medicines Market Size, Share, Growth, Trends, Scope, Regional Insights and Forecast 2021 - 2027

Published Date : Jul 2020 | No. of Pages : 200 Pages | Category : Healthcare


Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Geriatric Medicines Market, By Therapeutic Category

7.1. Geriatric Medicines Market, by Therapeutic Category Type, 2021-2027

7.1.1. Analgesic

7.1.1.1. Market Revenue and Forecast (2016-2027)

7.1.2. Antihypertensive

7.1.2.1. Market Revenue and Forecast (2016-2027)

7.1.3. Statins

7.1.3.1. Market Revenue and Forecast (2016-2027)

7.1.4. Antidiabetic

7.1.4.1. Market Revenue and Forecast (2016-2027)

7.1.5. Proton Pump Inhibitor

7.1.5.1. Market Revenue and Forecast (2016-2027)

7.1.6. Anticoagulant

7.1.6.1. Market Revenue and Forecast (2016-2027)

7.1.7. Antipsychotic and Antidepressant

7.1.7.1. Market Revenue and Forecast (2016-2027)

7.1.8. Others

7.1.8.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Geriatric Medicines Market, By Condition

8.1. Geriatric Medicines Market, by Condition, 2021-2027

8.1.1. Cardiovascular

8.1.1.1. Market Revenue and Forecast (2016-2027)

8.1.2. Arthritis

8.1.2.1. Market Revenue and Forecast (2016-2027)

8.1.3. Diabetes

8.1.3.1. Market Revenue and Forecast (2016-2027)

8.1.4. Neurological

8.1.4.1. Market Revenue and Forecast (2016-2027)

8.1.5. Cancer

8.1.5.1. Market Revenue and Forecast (2016-2027)

8.1.6. Osteoporosis

8.1.6.1. Market Revenue and Forecast (2016-2027)

8.1.7. Respiratory

8.1.7.1. Market Revenue and Forecast (2016-2027)

8.1.8. Others

8.1.8.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Geriatric Medicines Market, By Distribution Channel 

9.1. Geriatric Medicines Market, by Distribution Channel, 2021-2027

9.1.1. Hospital Pharmacies

9.1.1.1. Market Revenue and Forecast (2016-2027)

9.1.2. Retail Pharmacies

9.1.2.1. Market Revenue and Forecast (2016-2027)

9.1.3. Online Pharmacies

9.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Geriatric Medicines Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.1.2. Market Revenue and Forecast, by Condition (2016-2027)

10.1.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.1.4.2. Market Revenue and Forecast, by Condition (2016-2027)

10.1.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.1.5.2. Market Revenue and Forecast, by Condition (2016-2027)

10.1.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.2.2. Market Revenue and Forecast, by Condition (2016-2027)

10.2.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.2.4.2. Market Revenue and Forecast, by Condition (2016-2027)

10.2.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.2.5.2. Market Revenue and Forecast, by Condition (2016-2027)

10.2.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.2.6.2. Market Revenue and Forecast, by Condition (2016-2027)

10.2.6.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.2.7.2. Market Revenue and Forecast, by Condition (2016-2027)

10.2.7.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.3.2. Market Revenue and Forecast, by Condition (2016-2027)

10.3.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.3.4.2. Market Revenue and Forecast, by Condition (2016-2027)

10.3.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.3.5.2. Market Revenue and Forecast, by Condition (2016-2027)

10.3.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.3.6.2. Market Revenue and Forecast, by Condition (2016-2027)

10.3.6.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.3.7.2. Market Revenue and Forecast, by Condition (2016-2027)

10.3.7.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.4.2. Market Revenue and Forecast, by Condition (2016-2027)

10.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.4.4.2. Market Revenue and Forecast, by Condition (2016-2027)

10.4.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.4.5.2. Market Revenue and Forecast, by Condition (2016-2027)

10.4.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.4.6.2. Market Revenue and Forecast, by Condition (2016-2027)

10.4.6.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.4.7.2. Market Revenue and Forecast, by Condition (2016-2027)

10.4.7.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.5.2. Market Revenue and Forecast, by Condition (2016-2027)

10.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.5.4.2. Market Revenue and Forecast, by Condition (2016-2027)

10.5.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Therapeutic Category (2016-2027)

10.5.5.2. Market Revenue and Forecast, by Condition (2016-2027)

10.5.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2027)

Chapter 11. Company Profiles

11.1. Pfizer, Inc.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Merck & Co., Inc.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. AstraZeneca

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Bristol-Myers Squibb Company

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Novartis AG

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Sanofi S.A.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. GlaxoSmithKline plc Eli Lilly and Company

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Abbott Laboratories

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Boehringer Ingelheim GmbH

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Audiology Devices Market (By Product: Hearing Aids, Cochlear Implants; By Technology: Digital, Analog; By Sales Channel: Retail, E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Micro-pumps Market (By Product: Mechanical, Non-mechanical; By Application: Drug Delivery, Medical Devices; By End Use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    U.S. Behavioral Health Care Software And Services Market (By Component: Software, Support Services; By Delivery Model; By Function; By End Use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Medical Imaging Market (By Product: X-ray, CT, MRI, Ultrasound; By End-use: Hospitals, Diagnostic Imaging Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...
  • Featured Research Reports

    Medical Imaging Phantoms Market (By Device Type: X-ray, Ultrasound, CT, MRI; By End Use; By Material: Simulating Organs, False Organs) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

    Read more...